Cargando…

Vaccine-induced pseudothrombocytopenia after Ad26.COV2.S vaccination

Detalles Bibliográficos
Autores principales:	Kemper, Marcel, Berssenbrügge, Christoph, Lenz, Georg, Mesters, Rolf Michael
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2021
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8352752/ https://www.ncbi.nlm.nih.gov/pubmed/34374813 http://dx.doi.org/10.1007/s00277-021-04611-y

Ejemplares similares

A case report of vaccine-induced immune thrombocytopenia and thrombosis syndrome after Ad26.COV2.S vaccine (Janssen/Johnson & Johnson)()
por: Castan, Maxime, et al.
Publicado: (2022)

Guillain-Barré syndrome and fulminant encephalomyelitis following Ad26.COV2.S vaccination: double jeopardy
por: Stefanou, Maria Ioanna, et al.
Publicado: (2022)

Ethylenediaminetetraacetic acid-dependent pseudothrombocytopenia, presenting as spurious pancytopenia, associated with risperidone
por: Mamtani, Harkishan, et al.
Publicado: (2023)

Ethylene diamine tetra aceticacid pseudothrombocytopenia: A must to know entity for Anaesthesiologists
por: Sudha, P, et al.
Publicado: (2013)

Characteristics of VITT antibodies in patients vaccinated with Ad26.COV2.S
por: Huynh, Angela, et al.
Publicado: (2022)

Myocarditis following rAd26 and rAd5 vector‐based COVID‐19 vaccine: correspondence
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2022)

Pseudothrombocytopenia in a patient with bipolar type 2 disorder on lurasidone: A case report
por: Sakhardande, Kasturi Atmaram, et al.
Publicado: (2022)

Pseudothrombocytopenia Inducing Nonindicated Platelet Transfusion after Cardiac Surgery
por: Ceran, Enise, et al.
Publicado: (2021)

LGI-1 encephalopathy following ChAdOx1 nCov-19 vaccination
por: Garibashvili, Tamara, et al.
Publicado: (2022)

Thrombotic Thrombocytopenia after Ad26.COV2.S Vaccination
por: Muir, Kate-Lynn, et al.
Publicado: (2021)

Ad26 vaccine protects against SARS-CoV-2 severe clinical disease in hamsters
por: Tostanoski, Lisa H., et al.
Publicado: (2020)

Generalized Edema and Pseudothrombocytopenia After ChAdOx1 nCoV-19 COVID-19 Vaccination: A Case Report
por: Bokel, Joanna, et al.
Publicado: (2022)

Rhabdomyolysis Following Ad26.COV2.S COVID-19 Vaccination
por: Gelbenegger, Georg, et al.
Publicado: (2021)

Effectiveness of Ad26.COV2.S Vaccine vs BNT162b2 Vaccine for COVID-19 Hospitalizations
por: Botton, Jérémie, et al.
Publicado: (2022)

Guillain-Barré Syndrome After Ad26.COV2.S Vaccination
por: Thant, Hein Linn, et al.
Publicado: (2022)

Multisystem Inflammatory Syndrome after Ad26.COV2.S vaccination
por: Bova, Carlo, et al.
Publicado: (2022)

Thrombotic Thrombocytopenic Purpura after Ad26.COV2-S Vaccination
por: Yocum, Andrew, et al.
Publicado: (2021)

Successful treatment of thromboses of major arteries after ChAdOx1 nCov-19 vaccination
por: Goereci, Yasemin, et al.
Publicado: (2021)

Thromboses of major arteries and ChAdOx1 nCov-19 vaccination
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2021)

Reply: Subacute thyroiditis after anti-SARS-CoV-2 (Ad5-nCoV) vaccine()
por: Flores-Rebollar, Armando
Publicado: (2022)

ChAdOx1 nCov-19 vaccine-induced thrombotic thrombocytopenic purpura successfully treated with plasmapheresis
por: Wang, Yen-Ching, et al.
Publicado: (2021)

Pseudothrombocytopenia--a cautionary tale.
por: Kettle, P., et al.
Publicado: (1991)

COVID‐19‐associated pseudothrombocytopenia
por: Van Dijck, Ruben, et al.
Publicado: (2021)

Immunogenicity and Reactogenicity of Vaccine Boosters after Ad26.COV2.S Priming
por: Sablerolles, Roos S.G., et al.
Publicado: (2022)

Enhanced immunity after Ad26.COV2.S vaccine breakthrough infection
por: Montefiori, David C.
Publicado: (2022)

Immune thrombocytopenic purpura after vaccination with COVID-19 vaccine (ChAdOx1 nCov-19)
por: Paulsen, Finn-Ole, et al.
Publicado: (2021)

Surgical Delay due to Ethylenediaminetetraacetic Acid-Induced Pseudothrombocytopenia
por: Kharel, Himal, et al.
Publicado: (2020)

EDTA‐induced pseudothrombocytopenia in hematopoietic stem cell donor
por: Tsubokura, Misato, et al.
Publicado: (2023)

De novo psoriasis induced by ChAdOx1-S COVID 19 vaccine()
por: Zaiem, Ahmed, et al.
Publicado: (2022)

Understanding risk of thrombosis with thrombocytopenia syndrome after Ad26.COV2.S vaccination
por: Kulkarni, Prathit A., et al.
Publicado: (2021)

Deep Venous Thrombosis after Ad26.COV2.S Vaccination in Adult Male
por: Hussain, Habiba, et al.
Publicado: (2021)

Widespread annular eruption after Ad26.COV2.S COVID-19 vaccine
por: Song, Eingun James, et al.
Publicado: (2021)

Thrombotic Thrombocytopenia after Ad26.COV2.S Vaccination — Response from the Manufacturer
por: Sadoff, Jerald, et al.
Publicado: (2021)

Can Pseudothrombocytopenia be recognised at first look?
por: Yilmaz, Seda, et al.
Publicado: (2023)

Drug-induced hepatitis (DIH) after SARS-CoV-2 vaccination
por: Asgarzdeh, Ali, et al.
Publicado: (2023)

Detection of pre-existing neutralizing antibodies against Ad26 in HIV-1-infected individuals not responding to the Ad26.COV2.S vaccine
por: Schmidt, Katja G., et al.
Publicado: (2023)

Serious adverse events following immunization after ChAdOx1 nCov-19 vaccination in India: a single center experience
por: Maurya, Miteshkumar Rajaram, et al.
Publicado: (2021)

Allergic reactions to the Ad26.COV2.S vaccine in South Africa
por: Peter, Jonny, et al.
Publicado: (2021)

Platelet activation and modulation in thrombosis with thrombocytopenia syndrome associated with ChAdOx1 nCov-19 vaccine
por: Scavone, Mariangela, et al.
Publicado: (2021)

Acute Arterial Occlusion Following ChAdOx1 nCov-19 (Oxford–AstraZeneca) Vaccination
por: Ali, Azhar, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_qqceqgcvdpr5ngttmc8q0k2i0a